Repligen (RGEN) Liabilities and Shareholders Equity (2011 - 2026)

Repligen (RGEN) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $3.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 1.67% year-over-year to $3.0 billion in Q2 2026; TTM through Jun 2026 was $11.8 billion, a 2.98% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, up 4.24% from the prior year.
• Liabilities and Shareholders Equity was $3.0 billion for Q2 2026 at Repligen, up from $2.9 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $3.0 billion in Q2 2026 and troughed at $2.4 billion in Q1 2022.
• A 5-year average of $2.7 billion and a median of $2.8 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity advanced 23.69% in 2022 and decreased 0.05% in 2025, its largest moves.
• Over 5 years, Liabilities and Shareholders Equity stood at $2.5 billion in 2022, then rose by 11.83% to $2.8 billion in 2023, then fell by 0.05% to $2.8 billion in 2024, then rose by 4.24% to $2.9 billion in 2025, then advanced by 0.02% to $3.0 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $3.0 billion (Q2 2026), $2.9 billion (Q1 2026), and $2.9 billion (Q4 2025), per Business Quant data.